Establishing the Role of Apoptosis and mtDNA in the Pathobiology of Lupus
Benjamin Kile, PhDMonash University, Clayton, Australia
Biological Role of FCRL Molecules in SLE Pathogenesis
Lupus Innovation Award (LIA)
The Lupus Innovation Award offer up to $150,000/year total costs for up to 2 years. They provide early stage support for highly innovative approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches.
2019 Funded Grants
Monash University, Clayton, Australia
The Role of Microglial Subsets in Driving Neuropsychiatric Symptoms of SLE
Carla Cuda, PhDNorthwestern University Feinberg School of Medicine
Circadian Dysregulation of Immune Function in SLE
Anne Davidson, MBBSFeinstein Institutes for Medical Research
Contribution of Dysregulated Granulopoiesis to SLE Pathogenesis
Neelakshi Jog, PhDOklahoma Medical Research Foundation
Shining a Light on the Drivers of Photosensitivity in Systemic Lupus
Michelle Kahlenberg, MD, PhDUniversity of Michigan
New mechanisms for Thrombosis and Atherosclerosis in SLE and APS
Yee Ling Wu, PhDLoyola University Chicago Health Sciences Division
2018 Funded Grants
Ferroptosis as a novel driver of inflammation in lupus nephritis
Erika Boesen, PhDUniversity of Nebraska Medical Center
Age-Associated B cells in Autoimmune Lupus
Kevin Nickerson, PhDUniversity of Pittsburgh
Genetically Engineering Regulatory T Cells to Treat SLE
Joshua Ooi, PhDMonash University
Examining the Role of T cell Exhaustion in Lupus Pathogenesis
Jeremy Tilstra, MD, PhDUniversity of Pittsburgh
Epigenetic Regulation of Il2 by ATF7ip – Implications for SLE
Michael Waterfield, MD, PhDUniversity of California, San Francisco
Lymphatic Regulation and Photosensitivity
Theresa Lu, MD, PhDThe Hospital for Special Surgery
2017 Funded Grants
Immunotargeting of T Follicular Helper (Tfh) Cells for SLE Treatment
Andre Ballesteros-Tato, PhDUniversity of Alabama at Birmingham
Targeting EZH2 in Lupus
Amr Sawalha, MDUniversity of Pittsburgh
Mechanisms of the Autoimmune Germinal Center Response in SLE
Ziaur Rahman, MD, PhDPennsylvania State University College of Medicine
Regulation of CD11c+Tbet+ B Cells in Lupus
Alessandra B. Pernis, MDThe Hospital for Special Surgery
Targeting Immunometabolism and Co-stimulation in Combination Therapies in Lupus
Laurence Morel, PhDUniversity of Florida College of Medicine
Targeting Nicotinic Receptors to Reduce Inflammation Associated With SLE
Keisa Williams Mathis, PhDUniversity of Texas Health Science Center at Fort Worth
Characterization of Chemokine Producing Effector B Cells in SLE
Frances E. Lund, PhDUniversity of Alabama at Birmingham
Neutrophil Elastase as a Therapeutic Target in Lupus
Jason S. Knight, MD, PhDUniversity of Michigan Medical School
Unexpected Role(s) for IRF5 Risk Variants in SLE Pathogenesis
Betsy Jo Barnes, PhDThe Feinstein Institute for Medical Research